Literature DB >> 10961913

l-glutamate as a central neurotransmitter: looking back.

J C Watkins1.   

Abstract

The high concentration in brain of unbound l-glutamic acid (in its anionic form, l-glutamate) fuelled considerable speculation as to its role in central nervous function more than 50 years ago. Claims in the 1940s that it could improve cognitive acuity in patients with mental impairment were particularly intriguing, though later refuted. In the early 1950s Hayashi [(1954) Keio J. Med. 3, 183-192] found that l-glutamate could cause convulsions and proposed that it might be a central synaptic transmitter. Soon thereafter, Curtis and colleagues [Curtis, Phillis and Watkins (1959) Nature (London) 183, 611] showed that l-glutamate depolarized and excited central neurons, as expected for an excitatory transmitter; however, various aspects of the action of l-glutamate seemed to argue strongly against a transmitter function. This negative view prevailed for some 20 years, before compelling evidence for such a role was adduced. Over the last two decades, extensive research has revealed a host of glutamate receptor subtypes, subserving several different functions in excitatory synaptic transmission. This paper gives a very brief and personal overview of the development of the field over the last 50 years from a mainly pharmacological standpoint.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961913

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  19 in total

Review 1.  Contribution of Vesicular Glutamate Transporters to Stress Response and Related Psychopathologies: Studies in VGluT3 Knockout Mice.

Authors:  Hanga Réka Horváth; Csilla Lea Fazekas; Diána Balázsfi; Subodh Kumar Jain; József Haller; Dóra Zelena
Journal:  Cell Mol Neurobiol       Date:  2017-08-03       Impact factor: 5.046

Review 2.  NMDA receptors and metaplasticity: mechanisms and possible roles in neuropsychiatric disorders.

Authors:  Charles F Zorumski; Yukitoshi Izumi
Journal:  Neurosci Biobehav Rev       Date:  2012-01-02       Impact factor: 8.989

3.  mGluR7's lucky number.

Authors:  P Jeffrey Conn; Colleen M Niswender
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

4.  Newfound effect of N-acetylaspartate in preventing and reversing aggregation of amyloid-beta in vitro.

Authors:  Jean-Pierre Dollé; Jeffrey M Rodgers; Kevin D Browne; Thomas Troxler; Feng Gai; Douglas H Smith
Journal:  Neurobiol Dis       Date:  2018-05-31       Impact factor: 5.996

5.  Syntheses of 2-amino and 2-halothiazole derivatives as high-affinity metabotropic glutamate receptor subtype 5 ligands and potential radioligands for in vivo imaging.

Authors:  Fabrice G Siméon; Matthew T Wendahl; Victor W Pike
Journal:  J Med Chem       Date:  2011-01-05       Impact factor: 7.446

6.  Expression of vesicular glutamate transporters type 1 and 2 in sensory and autonomic neurons innervating the mouse colorectum.

Authors:  Pablo R Brumovsky; David R Robinson; Jun-Ho La; Kim B Seroogy; Kerstin H Lundgren; Kathryn M Albers; Michael E Kiyatkin; Rebecca P Seal; Robert H Edwards; Masahiko Watanabe; Tomas Hökfelt; G F Gebhart
Journal:  J Comp Neurol       Date:  2011-11-01       Impact factor: 3.215

7.  Interactions between the mGluR2/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys.

Authors:  Rayna M Bauzo; Heather L Kimmel; Leonard L Howell
Journal:  Pharmacol Biochem Behav       Date:  2009-08-22       Impact factor: 3.533

8.  Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system.

Authors:  Valentina Alda Carozzi; Annalisa Canta; Norberto Oggioni; Cecilia Ceresa; Paola Marmiroli; Jan Konvalinka; Chiara Zoia; Mario Bossi; Carlo Ferrarese; Giovanni Tredici; Guido Cavaletti
Journal:  J Anat       Date:  2008-11       Impact factor: 2.610

Review 9.  Kynurenines and Glutamate: Multiple Links and Therapeutic Implications.

Authors:  R Schwarcz
Journal:  Adv Pharmacol       Date:  2016-03-11

Review 10.  What is the real physiological NO concentration in vivo?

Authors:  Catherine N Hall; John Garthwaite
Journal:  Nitric Oxide       Date:  2009-07-12       Impact factor: 4.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.